Cargando…
Diagnosis, biology and epidemiology of oligometastatic breast cancer
Does oligometastatic breast cancer (OMBC) deserve a dedicated treatment? Although some authors recommend multidisciplinary management of OMBC with a curative intent, there is no evidence proving this strategy beneficial in the absence of a randomized trial. The existing literature sheds little light...
Autores principales: | Lacaze, Jean-Louis, Aziza, Richard, Chira, Ciprian, De Maio, Eleonora, Izar, Françoise, Jouve, Eva, Massabeau, Carole, Pradines, Anne, Selmes, Gabrielle, Ung, Mony, Zerdoud, Slimane, Dalenc, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441842/ https://www.ncbi.nlm.nih.gov/pubmed/34252822 http://dx.doi.org/10.1016/j.breast.2021.06.010 |
Ejemplares similares
-
Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes
por: Glemarec, Gauthier, et al.
Publicado: (2022) -
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience
por: Dejean, Romain, et al.
Publicado: (2022) -
Delayed Hypersensitivity Reaction to Titanium-coated Polypropylene Mesh in Breast Reconstruction
por: Jouve, Eva, et al.
Publicado: (2022) -
(18)F-Fluorine-18-l-dihydroxyphenylalanine ((18)F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of (18)F-FDOPA
por: Aziz, Anne-Laure, et al.
Publicado: (2015) -
Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)